Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Jun;96(23):e7098.
doi: 10.1097/MD.0000000000007098.

Use of sugammadex in a patient with progressive muscular atrophy and in a patient with amyotrophic lateral sclerosis: Case report

Jae Hwa Yoo  1 , Soon Im Kim, Sun Young Park, Mi Roung Jun, Yong Eun Kim, Hyoung June Kim
Affiliations
Case Reports

Use of sugammadex in a patient with progressive muscular atrophy and in a patient with amyotrophic lateral sclerosis: Case report

Jae Hwa Yoo et al. Medicine (Baltimore). 2017 Jun.

Erratum in

Abstract

Introduction: We herein present 2 cases involving the combination of rocuronium and sugammadex in patients with motor neuron disease. The patients were a 54-year-old man with progressive muscular atrophy who underwent removal of internal fixators in the arm and leg, and a 66-year-old woman with amyotrophic lateral sclerosis who underwent skin grafting in the left lower leg. General anesthesia was induced with propofol, rocuronium, and remifentanil and maintained with desflurane and remifentanil. At the end of the surgical procedure, we administered sugammadex. Three or 4 minutes after administration of sugammadex, the patients began to breathe spontaneously and were extubated without complications.

Conclusion: Sugammadex can be used successfully to reverse neuromuscular blockade in patients with motor neuron disease.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

References

    1. Cooperman LH. Succinylcholine-induced hyperkalemia in neuromuscular disease. JAMA 1970;213:1867–71. - PubMed
    1. Rosenbaum KJ, Neigh JL, Strobel GE. Sensitivity to nondepolarizing muscle relaxants in amyotrophic lateral sclerosis: report of two cases. Anesthesiology 1971;35:638–41. - PubMed
    1. Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007;104:575–81. - PubMed
    1. Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet 2007;369:2031–41. - PubMed
    1. Liewluck T, Saperstein DS. Progressive muscular atrophy. Neurol Clin 2015;33:761–73. - PubMed

Publication types